[Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
Yi SH, Xu Y, Zou DH, An G, Zhao YZ, Qi JY, Qiu LG.
Yi SH, et al. Among authors: an g.
Zhonghua Xue Ye Xue Za Zhi. 2009 May;30(5):307-12.
Zhonghua Xue Ye Xue Za Zhi. 2009.
PMID: 19799125
Chinese.
RESULTS: The adverse prognostic factors including LDH elevation, ECOG score > or =2, higher IPI and aaIPI score, B symptom, hepatomegaly, splenomegaly, hemoglobin <110 g/L, platelet <100 x 10(9)/L and serum albumin <35 g/L were more prevalent in DLBCL pa …
RESULTS: The adverse prognostic factors including LDH elevation, ECOG score > or =2, higher IPI and aaIPI score, B symptom, hepatomegaly, …